Theranos' relationship with Walgreens may be fraying after the drugstore chain announced it will delay the opening of blood-testing centers until questions about the startup's technology are answered.
Walgreens will not expand its partnership with Walgreens beyond the 41 stores that already have Theranos' wellness centers, according to the Wall Street Journal. However, talks between the two companies are continuing, the paper reports.
Walgreens met with Theranos CEO Elizabeth Holmes after WSJ reported that former employees of the lab company said they were unsure of the accuracy of its blood testing technology and that the U.S. Food and Drug Administration had visited the company unannounced and concluded from its inspection that the "nanotainers" the company uses to collect and store blood are an unapproved medical device.
Holmes disputed the claims last week, calling them "misleading." She did, however, say that the company is in a "pause period" while it waits for FDA approval of its technology. Article